The effect of mycophenolate mofetil on primary and secondary treatment of primary glomerulonephritis and lupus nephritis

[1] Eugui EM(1991)Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion Scand J Immunol 33 161-173

[2] Almquist SJ(1993)Mycophenolate mofetil (RS-61443): mechanism of action and effects in transplantation Transpl Rev 7 129-139

[3] Muller CD(1994)Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation Transpl Proc 26 3205-3210

[4] Allison AC(1993)Mycophenolic acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosylation of adhesion molecules Transpl Proc 25 67-70

[5] Allison AC(1993)Brequinar sodium, mycophenolic acid, and cyclosporin A inhibit different stages of IL-4 or IL 13 d human IgG4 and IgE production in vitro Ann N Y Acad Sci 696 108-122

[6] Eugut EM(1999)Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells Transpl Proc 31 1250-1252

[7] Sollinger HW(1995)Mycophenolate mofetil for prevention of acute rejection in primary cadaveric renal allograft recipients. US Renal Transplant Mycophenolate Mofetil Study Group Transplantation 60 225-232

[8] Allison AC(1996)A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation Transplantation 61 1029-1037

[9] Allison AC(2007)Is it worth using daclizumab induction therapy with mycophenolate mofetil-based immunosuppressive regimens in live related donor kidney transplantation? A long-term follow up Int Urol Nephrol 39 317-319

[10] Kowalski WJ(2000)Mycophenolate mofetil reduces late renal allograft loss of acute rejection Transplantation 69 2405-2409

[1] Eugui EM(1991)Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion Scand J Immunol 33 161-173

[2] Almquist SJ(1993)Mycophenolate mofetil (RS-61443): mechanism of action and effects in transplantation Transpl Rev 7 129-139

[3] Muller CD(1994)Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation Transpl Proc 26 3205-3210

[4] Allison AC(1993)Mycophenolic acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosylation of adhesion molecules Transpl Proc 25 67-70

[5] Allison AC(1993)Brequinar sodium, mycophenolic acid, and cyclosporin A inhibit different stages of IL-4 or IL 13 d human IgG4 and IgE production in vitro Ann N Y Acad Sci 696 108-122

[6] Eugut EM(1999)Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells Transpl Proc 31 1250-1252

[7] Sollinger HW(1995)Mycophenolate mofetil for prevention of acute rejection in primary cadaveric renal allograft recipients. US Renal Transplant Mycophenolate Mofetil Study Group Transplantation 60 225-232

[8] Allison AC(1996)A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation Transplantation 61 1029-1037

[9] Allison AC(2007)Is it worth using daclizumab induction therapy with mycophenolate mofetil-based immunosuppressive regimens in live related donor kidney transplantation? A long-term follow up Int Urol Nephrol 39 317-319

[10] Kowalski WJ(2000)Mycophenolate mofetil reduces late renal allograft loss of acute rejection Transplantation 69 2405-2409